Effects of Magnetic Nano-Controlled Release Paclitaxel on the Growth of Esophageal Carcinoma Cell Line Eca109

Ping Chen,Rui-Hua Shi,Ting-Sheng Ling
DOI: https://doi.org/10.11569/wcjd.v14.i35.3348
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To observe the effects of magnetic nanocontrolled paclitaxel at different concentrations on the growth of esophageal carcinoma cell line Eca109. METHODS: Eca109 cells in logarithmic growth phase were treated by magnetic nano-controlled release paclitaxel at different concentrations, fluorouracil (5-FU) and Taisu, while dimethylsurfoxide (DMSO) and RPMI 1640 were used in the control cells. MTT assay was used to examine the inhibitory rate through the absorbency of 24, 48, and 72 h. After Eca109 cells were disposed by magnetic nano-controlled release paclitaxel at different concentrations for 72 h, the cellular ultrastructure was observed under electron microscope and cell cycle and apoptosis were analyzed by flow cytometry. RESULTS: Magnetic nano-controlled release paclitaxel inhibited the proliferation of Eca109 cell in vitro, and the effect had characteristic of slower release in comparison with that of 5-FU or Taisu (78.1% vs 60.0%, 63.8%, P < 0.01). Chromation condensation, nucleic fragmentation and apoptic body formation were found in drug-treated cells by electron microscopy. Flow cytometry analysis showed an obvious apoptotic peak before G1 peak and magnetic nanocontrolled release paclitaxel blocked Eca109 cells in G2-M phase, which was associated with the concentrations. CONCLUSION: Magnetic nano-controlled release paclitaxel can induce apoptosis and block cell cycle of esophageal cells.
What problem does this paper attempt to address?